Report
Hugo Solvet

BIOMÉRIEUX: Tracking Medicare contractors: reassuring short-term outlook for FilmArray | NEUTRAL | EUR70

BIOMÉRIEUX - NEUTRAL | EUR70
Tracking Medicare contractors: reassuring short-term outlook for FilmArray

70% of Medicare outpatients can still benefit from FilmArray
Roll-over to commercial payers has a small effect
Underlying
BioMerieux SA

Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Hugo Solvet

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch